SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-24-000097
Filing Date
2024-05-20
Accepted
2024-05-20 20:10:44
Documents
1
Period of Report
2024-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716250233.html 4  
1 FORM 4 wk-form4_1716250233.xml 4 21452
  Complete submission text file 0001626199-24-000097.txt   23079
Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 24966587

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)